Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jun 13;6:2054358119854113. doi: 10.1177/2054358119854113

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Any use of antihyperglycemic classes by CKD stage.

Note. CKD = chronic kidney disease; DPP-4 = dipeptidyl peptidase-4; SGLT2 = sodium glucose co-transporter 2; GLP-1 = glucagon-like peptide 1. Other includes Acarbose, Orlistat, Pioglitazone, and Rosiglitazone. Any participant can be counted in more than one class of antihyperglycemic agent.